Ohmura H, Yamaguchi K, Hanamura F, Ito M, et al. OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody. Br J Cancer 2020 Mar 23. pii: 10.1038/s41416-020-0810.
PMID: 32203221